How many studies have been conducted on Sugammadex?

BiohacksAI has indexed 300 PubMed studies on Sugammadex, including 30 randomized controlled trials (RCTs). 66% of studies involve human subjects.

What are the main research areas for Sugammadex?

The primary research domains for Sugammadex are 💪 Strength & Power, 🫘 Kidney, 🫁 Respiratory. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Sugammadex

A gamma-cyclodextrin that functions as a reversal agent for the neuromuscular blocker ROCURONIUM BROMIDE.

300+ PubMed studies analyzed · 30 RCTs · Evidence Score: 54.2

Research Domains

Sugammadex has been studied across 13 research domains including 💪 Strength & Power, 🫘 Kidney, 🫁 Respiratory, ❤️ Cardiovascular, 🧠 Focus & Attention. The primary research focus is 💪 Strength & Power with 5% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sugammadex is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.